Merck & Co., Inc. — Director's Dealing 2019

Nov 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-10-30

Reporting Person: Clyburn Frank (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-30	Common Stock	M	2287.0000	$0.0000	Acquired	73031.9680	Direct
2019-10-30	Common Stock	F	1127.0000	$85.1000	Disposed	71904.9680	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-30	Restricted Stock Unit	$	M	2287.0000	Disposed	2021-10-30	Common Stock (2287.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - 401(k) Plan	1510.4352	Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through October 7, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.